在中日友好医院医生被举报风波中，一位名为董某莹（下称董小姐）的规培生卷入其中。 据第一财经记者调查，董小姐目前已不在中日友好医院胸外科规培，现职为中国医学科学院肿瘤医院泌 尿外科住院医师（规培阶段）。 更多内容推荐阅读→ 董小姐是如何用3年完成11篇跨学科论文的？ ...

Group 1 - The core viewpoint emphasizes that public hospitals must focus on high-quality development by enhancing technology, management, and services while ensuring public welfare and improving efficiency, ultimately transitioning from "scale expansion" to "value-based healthcare" [1] - The key strategies for cancer hospital discipline construction include focusing on "true needs," "full cycle," and "driving capability," which aim to align discipline development with public health needs, provide comprehensive services, and elevate regional cancer prevention and treatment levels [1] Group 2 - The importance of the Multidisciplinary Team (MDT) model in cancer treatment is highlighted, with a focus on creating a quantifiable and replicable system rather than relying on individual efforts. The establishment of a "lung cancer comprehensive diagnosis and treatment model" is shared as a successful example [2] - The MDT team structure is based on a "triangular" framework with fixed teams, clear roles, and a chief responsibility system, along with standardized processes and feedback mechanisms to enhance collaboration and patient care [2] Group 3 - The development of talent is crucial for advancing public hospital quality, with a focus on a closed-loop strategy of attracting, nurturing, utilizing, and retaining talent. This includes targeted recruitment, practical training, empowerment in research and clinical roles, and fostering a sense of mission among staff [3] - Future plans include establishing a major clinical research center for new cancer drugs in Southwest China, promoting standardized treatment for cancer pain in grassroots settings, and creating an intelligent diagnostic platform for cancer diseases to improve resource allocation [3]

Financial Data and Key Metrics Changes - The company reported net income attributable to UHS per diluted share of $4.8 for Q1 2025, with adjusted net income per diluted share at $4.84 [4] - Adjusted admissions to acute care hospitals increased by 2.4% year-over-year [4] - Same facility net revenues in the Acute Care Hospital segment increased by 5% compared to Q1 2024 [5] - EBITDA increased by 21% after excluding Medicaid supplemental payments [5] - Cash generated from operating activities decreased to $360 million from $396 million in Q1 2024 due to delays in Medicaid payments [6] Business Line Data and Key Metrics Changes - Same facility net revenues at behavioral health hospitals increased by 5.5%, driven by a 5.8% increase in revenue per adjusted day [5] - Adjusted patient days were relatively flat compared to the prior year, impacted by the leap day in 2024 and adverse weather conditions [6] Market Data and Key Metrics Changes - The company experienced a reacceleration of patient day growth in March 2025 [6] - The Nevada supplemental program received $82 million in payments in April, related to Q1 revenues [6] Company Strategy and Development Direction - The company is focused on managing operating expenses effectively across both business segments [8] - The opening of new facilities, such as West Henderson Hospital, is expected to contribute positively to EBITDA [10] - The company reiterated its full-year earnings guidance despite uncertainties in the external operating environment [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in underlying business performance despite external uncertainties [11] - The company anticipates achieving a behavioral patient day revenue growth target of 2.5% to 3% for the year [15] - Management acknowledged ongoing challenges in labor markets but noted improvements in staffing levels [78] Other Important Information - The company spent $239 million on capital expenditures in Q1 2025 and repurchased $1 million of its own shares [7] - The company has $1.02 billion of available borrowing capacity under its revolving credit facility [7] Q&A Session Summary Question: Insights on behavioral health volumes and future guidance - Management confirmed that the full-year guidance of 2.5% to 3% patient day revenue growth remains reasonable despite a slow start in Q1 [15][20] Question: Updates on Medicaid supplemental payment programs - Management indicated that approvals for Tennessee and D.C. programs are expected, but timing remains uncertain [16][17] Question: Impact of tariffs on supply chain - Management noted that approximately 75% of supply chain purchases are insulated from tariffs, and they are monitoring vendor responses [26][28] Question: Trends in acute business and acuity - Management reported that acuity was muted in Q1 due to a busy flu season but expects normalization as the year progresses [62] Question: Expense management and premium labor costs - Premium pay costs were consistent at $63 million, and management is optimistic about sustaining operating expense controls [70][72] Question: Updates on commercial rate negotiations - Management stated that overall guidance for acute care revenue growth remains at 5% to 6%, with no significant impact from payer behavior noted [105][106]

2025.04. 29 本文字数：1348，阅读时长大约2分钟 导读 ：中日友好医院胸外科医生肖飞因在手术中突然离场引发争议，最终被医院开除党籍并解除聘用关系。 作者 | 第一财经 钱童心 封面图丨 AI配图 在近日针对中日友好医院胸外科医生肖飞的一份举报材料中，一场备受争议的手术细节浮出水面。举报信称，肖飞曾在去年7月份的一台手术中无 故离场，把已经麻醉的患者在手术室"晾"了40分钟。 对此，肖飞在4月28日接受媒体采访时提供了一份《关于2024年7月5日手术室纠纷事件的澄清》文件。文件附有相关手术经过和患者的出院记 录。 手术记录显示，患者8：13分入室，两分钟后完成麻醉前核对，8：51单肺通气，8：53分时完成术前核对。而冲突爆发于9点左右手术正要开始 时。 据肖飞所述，他在手术准备工作就绪后，与护士王某有过往冲突，因为"气得手抖"，且"平常有高血压"，"自觉头晕"和"非常不舒服"，于是"在确保 麻醉后的病人很安全"，"且有麻醉医生、台上护士在场看护的情况下"，下台，"摘掉手套、脱手术衣"，"调整身心状态"，在"平复心情后"返回手术 间顺利完成了手术。 据手术记录，这台手术涉及为一名59岁的女性患者进行 ...

来源|国际财闻汇 彭博社4月29日报道，华盛顿州议会在立法会议收官阶段通过系列新税改法案，剑指亚马逊、微软等科技巨头以填补创纪录的预算赤字。法案现提交 州长鲍勃·弗格森签署，新税制不仅影响科技产业，还将波及银行、超市、医院等领域，加剧企业经营成本压力。 目前，州长弗格森目前尚未明确签署意向。根据立法程序，其需在不足三周内作出决定，亦可召集特别会议重启审议。弗格森此前已否决过更激进的 增税提案，包含拟征全国首例财富税。尽管众议院未对财富税提案启动表决程序，参议院仍象征性通过相关提案。民主党领导人表示，未来将继续推 动财富税立法。 多个行业组织发出预警，新税制将推高运营成本，最终转嫁至消费者。华盛顿州医院协会测算，医疗系统到2027年将产生2.6亿美元资金缺口。食品 行业代表指出，税负叠加将抬高食品供应链各环节成本，影响终端零售价格。华盛顿州科技产业协会表示，虽然企业暂无立即搬离计划，但未来业务 扩张或将优先考虑低税负地区。持续攀升的税收成本正逼近企业战略调整临界点。 【 热门视频推荐 】 点击在 看 持续关注↓↓↓ 此次税改采取改良既有税制框架的策略：扩大销售税适用范畴、调升总收入税税率、新增最高10%的资本利 ...

证券代码：600568 证券简称：ST 中珠 公告编号：2025-022 号 中珠医疗控股股份有限公司 2025 年第一季度主要经营数据公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上市公司行业信息披露指引第一号——房地产》《上市公司行业信息披露 指引第六号——医药制造》及上海证券交易所《关于做好主板上市公司 2025 年第一季 度报告披露工作的重要提醒》的要求，中珠医疗控股股份有限公司（以下简称"中珠 医疗"或"公司"）现将 2025 年第一季度主要经营数据披露如下： 一、主营业务分析 | 行 业 | 营业收入 | 营业成本 | 毛利率 | 营业收入比 | 营业成本比 | | --- | --- | --- | --- | --- | --- | | | （2025 年 1-3 月） | （2025 年 1-3 月） | | 上年增减（%） | 上年增减（%） | | 医疗器械 | 2,225,707.17 | 1,631,908.30 | 26.68 | -59.06 | -55.10 | | 医疗 ...

Investment Rating - The industry investment rating is "Outperform" [2] Core Viewpoints - Recent developments from Johnson & Johnson regarding PFA products indicate that domestic PFA brands are expected to enter a commercialization fast track in 2025, with significant growth potential in the market [5][6][17] - The medical biology sector has shown a weekly increase of 1.16%, outperforming the CSI 300 index by 0.77 percentage points, with the medical research outsourcing sector experiencing the highest growth of 6.34% [18][21] Summary by Sections Weekly Insights - Johnson & Johnson presented three key PFA products at the HRS2025 conference, showcasing their safety, effectiveness, and usability [14][15] - The domestic PFA market is projected to reach 1.3 billion yuan in 2025 and exceed 16.3 billion yuan by 2032, with a compound annual growth rate of 43.73% [17] Sector Performance - The medical research outsourcing sector had the highest weekly increase of 6.34%, while the vaccine sector saw the largest decline of 3.78% [7][21] - The report highlights a significant divergence in performance across sub-sectors, with the medical biology sector ranking 15th among 31 sub-industries [18][24] Recommended and Benefiting Stocks - Recommended stocks include Microelectrophysiology, Maipu Medical, and Yingke Medical [8] - Benefiting stocks include Huatai Medical, Weili Medical, and BGI Genomics [8][30] Market Trends - The report notes that the medical device sector is expected to benefit from policies promoting equipment upgrades and procurement, with a focus on AI integration in medical imaging and surgical applications [25][29] - The IVD sector is anticipated to see growth driven by AI-assisted diagnostics and favorable government policies [29] Specific Sector Analysis - The blood products sector is facing challenges due to high inventory levels and competitive pressures, but long-term demand for albumin remains stable [32] - The offline pharmacy sector is undergoing consolidation, with leading pharmacies expected to benefit from increased customer traffic and improved profit margins [33][34]

1. 精神疾病相关代谢综合征患者 药物性代谢异常：长期使用抗精神障碍药物（如奥氮平、喹硫平、米氮平、丙戊酸钠等）导致体重增 加、胰岛素抵抗、血脂异常的患者。 共病代谢疾病：精神分裂症、双相障碍等患者合并糖尿病、高血压、非酒精性脂肪肝等代谢性疾病，需 协同干预。 新京报讯（记者戴轩）精神疾病与体重异常常相伴而生。记者从北京安定医院获悉，该院体重管理与营 养多学科联合门诊将于4月29日开诊。 精神疾病与体重异常常相伴而生。精神疾病患者面临肥胖、代谢异常或营养不良等问题，这与药物副作 用、情绪性进食、代谢紊乱等密切相关。 为积极响应国家卫健委"体重管理年"行动号召，切实解决患者"治病易发胖、减重难坚持"的困扰，北京 安定医院整合多学科资源，正式开设"体重管理与营养多学科联合门诊"，为精神疾病合并体重问题的患 者提供"一站式"干预。该门诊由精神科、营养科、中医科、药事科等多团队提供服务。 接诊人群包括： 复发高危人群：通过体重管理降低代谢负担（如内脏脂肪堆积促炎状态），间接减少精神症状复发风 险。 生活方式重建：慢性精神疾病患者（如稳定期精神分裂症）的社区营养支持。 该门诊出诊时间为每周二上午8:00-12:00。出 ...

在随后举行的"艺术疗愈促进身心健康的探索与实践"研讨会上，第十二届全国政协社会和法制委员会副 主任张世平指出，要准确把握职工心理问题的差异性，维护职工心理健康是一项系统工程，政府应把心 理健康的系统化建设摆在更加突出的位置，进一步完善精神卫生相关法律法规，加大对心理健康服务的 政策倾斜和资金支持，提升精神卫生领域的科技创新能力；医院要注重关口前移，重视科学防控，着力 抓好前端预防、后端康复的工作；工会要注重维护职工健康权益，加强职工健康教育，倡导科学生活方 式，重视心理专业人才的培养。 北京小汤山医院党委书记张金霞介绍，小汤山医院具有得天独厚的自然环境，是开展人文艺术疗法、引 领新时代健康管理新理念和新模式的不二之选。依托独特的自然因子，医院致力于建立一套集温泉水 疗、森林康养、中医养护、药膳食疗、运动干预、物理治疗、艺术疗愈等于一体的全要素自然疗法体 系，打造健康中国的"小汤山模式"。 校对 卢茜 新京报讯（记者张秀兰）在"五一"国际劳动节来临之际，北京小汤山医院举办了"向劳动者致敬"主题活 动，面向社会发布职工身心健康关爱项目，包含健康管理、中医养生等九大特色板块，致力于从身体到 心理全方位守护职工健康。 ...

Financial Data and Key Metrics Changes - In the first quarter of 2025, diluted earnings per share, as adjusted, increased more than 20% year-over-year to $6.45 [9] - Adjusted EBITDA grew 11.3% over the prior year quarter, with an adjusted EBITDA margin improvement of 110 basis points [20][22] - Cash flow from operations was $1.65 billion in the quarter, with a decrease attributed to working capital changes [24] Business Line Data and Key Metrics Changes - Inpatient admissions grew 2.6% year-over-year, equivalent admissions increased 2.8%, and emergency room visits rose by 4% [10] - Same facilities revenue grew almost 6%, driven by volume increases and approximately 3% higher revenue per equivalent admission [11] - Surgical volumes were mixed, with inpatient surgeries slightly up and outpatient cases down [10][33] Market Data and Key Metrics Changes - Same-facility managed care equivalent admissions increased by 5.4% compared to the prior year quarter, while same-facility equivalent exchange admissions surged by 22.4% [20] - Exchange volume represented about 8% of equivalent admissions and approximately 10% of revenues for the quarter [108] Company Strategy and Development Direction - The company is focused on maintaining operational discipline while continuing to invest in its strategic agenda, including increasing the number of facilities by 3.3% [12][13] - Capital allocation strategy includes $991 million in capital expenditures, $225 million in share repurchases, and $180 million in dividends [25] - The company is investing heavily in technology and digital transformation to improve operational efficiency and clinical care [132][133] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the overall demand for healthcare services and the company's ability to navigate through uncertain policy environments [14][18] - The company is developing plans to address potential adverse impacts from health policy changes and tariffs, drawing from experiences during the COVID-19 pandemic [17][75] - Management remains optimistic about maintaining market share gains and operational efficiencies despite competitive pressures [100][101] Other Important Information - The company reaffirmed its guidance ranges for the full-year 2025, indicating confidence in its operational performance [26] - The company reported an $18 million increase in net benefits related to Medicaid in the first quarter of 2025 compared to the prior year quarter [23] Q&A Session Summary Question: Any major changes in assumptions embedded in the reiteration of guidance? - Management stated that the first quarter performance was solid, and guidance for 2025 remains appropriate [31] Question: How do you get that much leverage this quarter? - Management explained that operating leverage is created by pushing more volume through the organization, which improves profitability and margins [42] Question: Can you clarify the revenue per adjusted admission increase? - Management noted that the increase was driven by payer mix trends and improved acuity, with managed care positioning improving year-over-year [55][59] Question: Any changes with MA plan behavior denials? - Management indicated that there were no significant changes in denials and underpayments that materially impacted financial results [68] Question: How is the surgical schedule and block time utilization looking? - Management believes that demand for healthcare will remain strong, with expectations for surgical volumes to recover [126] Question: Can you speak to your technology agenda? - Management highlighted significant investments in technology and digital transformation to enhance operational efficiency and clinical care [132][133]